10-Q Filing

Talkspace, Inc. CIK: 1803901 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0000950170-22-016051`
Period End Date	20220630
Filing Date	20220809
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	talk-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 58 Income Statement 70 Cash Flow Statement 64 Stockholders Equity 37

Balance Sheet 58 line items

Line Item	Tag	Value	Unit	Period
Allowance, Accounts Receivable	`AllowanceForDoubtfulAccountsReceivable`	$4.92M	USD	Point-in-time
Allowance, Accounts Receivable	`AllowanceForDoubtfulAccountsReceivable`	$4.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$198.26M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$166.62M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net of reserves of $4,698 and $4,918 as of June 30, 2022 and December 31, 2021, respectively	`AccountsReceivableNetCurrent`	$5.51M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net of reserves of $4,698 and $4,918 as of June 30, 2022 and December 31, 2021, respectively	`AccountsReceivableNetCurrent`	$7.16M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.94M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$9.56M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$177.72M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$213.33M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	152.86M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	157.37M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$624.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$623.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	157.37M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	152.86M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$2.90M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$3.44M	USD	Point-in-time
Goodwill	`Goodwill`	$6.13M	USD	Point-in-time
Goodwill	`Goodwill`	$6.13M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$85.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$82.00K	USD	Point-in-time
Total assets	`Assets`	$223.61M	USD	Point-in-time
Total assets	`Assets`	$187.47M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.81M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.43M	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$5.95M	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$7.19M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilitiesCurrent`	$10.90M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilitiesCurrent`	$12.56M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$27.18M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$24.66M	USD	Point-in-time
Warrant liabilities	`WarrantLiabilitiesNonCurrent`	$5.29M	USD	Point-in-time
Warrant liabilities	`WarrantLiabilitiesNonCurrent`	$4.07M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$86.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$267.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$31.33M	USD	Point-in-time
Total liabilities	`Liabilities`	$30.21M	USD	Point-in-time
Commitments and contingencies (Note 5)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 5)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock of $0.0001 par value-Authorized: 1,000,000,000 shares at June 30, 2022 and December 31, 2021; Issued and outstanding: 157,372,616 and 152,862,447 shares at June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$15.00K	USD	Point-in-time
Common stock of $0.0001 par value-Authorized: 1,000,000,000 shares at June 30, 2022 and December 31, 2021; Issued and outstanding: 157,372,616 and 152,862,447 shares at June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$15.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$372.15M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$363.79M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-214.91M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-171.53M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$176.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-109.20M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-98.90M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$202.26M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$192.27M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$157.25M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$223.61M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$187.47M	USD	Point-in-time

Income Statement 70 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$59.99M	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$30.98M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$58.14M	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$29.84M	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$30.43M	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$11.70M	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$21.51M	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$15.30M	USD	1 Quarter
Gross profit	`GrossProfit`	$14.55M	USD	1 Quarter
Gross profit	`GrossProfit`	$36.63M	USD	2 Qtrs
Gross profit	`GrossProfit`	$29.57M	USD	2 Qtrs
Gross profit	`GrossProfit`	$19.29M	USD	1 Quarter
Research and development, net	`ResearchAndDevelopmentExpense`	$10.61M	USD	2 Qtrs
Research and development, net	`ResearchAndDevelopmentExpense`	$4.78M	USD	1 Quarter
Research and development, net	`ResearchAndDevelopmentExpense`	$7.75M	USD	2 Qtrs
Research and development, net	`ResearchAndDevelopmentExpense`	$5.58M	USD	1 Quarter
Clinical operations	`OtherCostAndExpenseOperating`	$2.32M	USD	1 Quarter
Clinical operations	`OtherCostAndExpenseOperating`	$4.09M	USD	2 Qtrs
Clinical operations	`OtherCostAndExpenseOperating`	$3.99M	USD	2 Qtrs
Clinical operations	`OtherCostAndExpenseOperating`	$1.91M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$18.93M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$48.69M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$40.34M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$26.44M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$16.32M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$13.71M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$16.80M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$8.79M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$35.62M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$71.84M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$76.75M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$46.85M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-27.56M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-40.12M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-21.07M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-42.28M	USD	2 Qtrs
Financial expense, net	`InterestAndDebtExpenseIncome`	$996.00K	USD	2 Qtrs
Financial expense, net	`InterestAndDebtExpenseIncome`	$1.86M	USD	1 Quarter
Financial expense, net	`InterestAndDebtExpenseIncome`	$3.04M	USD	2 Qtrs
Financial expense, net	`InterestAndDebtExpenseIncome`	$2.87M	USD	1 Quarter
Loss before taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-43.16M	USD	2 Qtrs
Loss before taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-30.43M	USD	1 Quarter
Loss before taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-43.27M	USD	2 Qtrs
Loss before taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-22.93M	USD	1 Quarter
Taxes on income	`IncomeTaxExpenseBenefit`	$110.00K	USD	2 Qtrs
Taxes on income	`IncomeTaxExpenseBenefit`	$18.00K	USD	2 Qtrs
Taxes on income	`IncomeTaxExpenseBenefit`	$10.00K	USD	1 Quarter
Taxes on income	`IncomeTaxExpenseBenefit`	$89.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-43.38M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-12.74M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-30.44M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-43.18M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-23.02M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-20.36M	USD	1 Quarter
Earnings Per Share, Basic	`EarningsPerShareBasic`	$0.28	USD	2 Qtrs
Earnings Per Share, Basic	`EarningsPerShareBasic`	$0.15	USD	1 Quarter
Earnings Per Share, Basic	`EarningsPerShareBasic`	$1.15	USD	1 Quarter
Earnings Per Share, Basic	`EarningsPerShareBasic`	$2.15	USD	2 Qtrs
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$2.15	USD	2 Qtrs
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$0.15	USD	1 Quarter
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$1.15	USD	1 Quarter
Earnings Per Share, Diluted	`EarningsPerShareDiluted`	$0.28	USD	2 Qtrs
Weighted average number of common shares used in computing basic net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	155.71M	shares	1 Quarter
Weighted average number of common shares used in computing basic net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	20.10M	shares	2 Qtrs
Weighted average number of common shares used in computing basic net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	154.90M	shares	2 Qtrs
Weighted average number of common shares used in computing basic net loss per share	`WeightedAverageNumberOfSharesOutstandingBasic`	26.36M	shares	1 Quarter
Weighted average number of common shares used in computing diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	154.90M	shares	2 Qtrs
Weighted average number of common shares used in computing diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	20.10M	shares	2 Qtrs
Weighted average number of common shares used in computing diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	26.36M	shares	1 Quarter
Weighted average number of common shares used in computing diluted net loss per share	`WeightedAverageNumberOfDilutedSharesOutstanding`	155.71M	shares	1 Quarter

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-43.38M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-12.74M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-30.44M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.18M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-23.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-20.36M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$955.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$697.00K	USD	2 Qtrs
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	-	USD	2 Qtrs
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$175.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$6.21M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$16.71M	USD	2 Qtrs
Warrant change in fair value	`WarrantIssuanceCostAndChangeInFairValue`	$-3.04M	USD	2 Qtrs
Warrant change in fair value	`WarrantIssuanceCostAndChangeInFairValue`	$-1.22M	USD	2 Qtrs
Increase in accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$703.00K	USD	2 Qtrs
Increase in accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$1.65M	USD	2 Qtrs
Decrease (increase) in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$1.78M	USD	2 Qtrs
Decrease (increase) in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-5.62M	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$381.00K	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.83M	USD	2 Qtrs
(Decrease) increase in deferred revenues	`IncreaseDecreaseInDeferredCharges`	$1.24M	USD	2 Qtrs
(Decrease) increase in deferred revenues	`IncreaseDecreaseInDeferredCharges`	$-2.38M	USD	2 Qtrs
Decrease in accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-1.15M	USD	2 Qtrs
Decrease in accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-213.00K	USD	2 Qtrs
Increase in other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	2 Qtrs
Increase in other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$178.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-33.11M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-17.79M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$160.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$449.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-449.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-160.00K	USD	2 Qtrs
(Payments) proceeds from reverse capitalization, net of transaction costs	`ProceedsFromReverseCapitalizationNetOfTransactionCosts`	$251.32M	USD	2 Qtrs
(Payments) proceeds from reverse capitalization, net of transaction costs	`ProceedsFromReverseCapitalizationNetOfTransactionCosts`	$-645.00K	USD	2 Qtrs
Proceeds from borrowings	`ProceedsFromIssuanceOfDebt`	-	USD	2 Qtrs
Proceeds from borrowings	`ProceedsFromIssuanceOfDebt`	$6.00M	USD	2 Qtrs
Repayment of borrowings	`RepaymentsOfDebt`	-	USD	2 Qtrs
Repayment of borrowings	`RepaymentsOfDebt`	$6.00M	USD	2 Qtrs
Payment of debt issuance costs	`PaymentOfDeferredIssuanceCosts`	-	USD	2 Qtrs
Payment of debt issuance costs	`PaymentOfDeferredIssuanceCosts`	$50.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.89M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$2.35M	USD	2 Qtrs
Payments for employee taxes withheld related to vested stock-based awards	`PaymentsForEmployeeTaxesWithheldRelatedToRestrictedStockUnitsVested`	-	USD	2 Qtrs
Payments for employee taxes withheld related to vested stock-based awards	`PaymentsForEmployeeTaxesWithheldRelatedToRestrictedStockUnitsVested`	$67.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.64M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$253.16M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-31.63M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$234.93M	USD	2 Qtrs
Cash and cash equivalents at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$166.62M	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$198.26M	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.25M	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$248.17M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$166.62M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$198.26M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.25M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$248.17M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$101.00K	USD	2 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	$25.00K	USD	2 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaidNet`	$97.00K	USD	2 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Conversion of preferred stock to common stock	`ConversionOfStockAmountConverted1`	$111.28M	USD	2 Qtrs
Conversion of preferred stock to common stock	`ConversionOfStockAmountConverted1`	-	USD	2 Qtrs
Issuance of warrant and other costs related to the Credit Agreement	`PaymentOfNoncashFinancingIssuanceOfWarrantAndOtherCostsRelatedToTheCreditAgreement`	$175.00K	USD	2 Qtrs
Issuance of warrant and other costs related to the Credit Agreement	`PaymentOfNoncashFinancingIssuanceOfWarrantAndOtherCostsRelatedToTheCreditAgreement`	-	USD	2 Qtrs

Stockholders Equity 37 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$176.28M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-109.20M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-98.90M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$202.26M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$192.27M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$157.25M	USD	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	157.37M	shares	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	152.86M	shares	Point-in-time
Common stock issued related to exercise of warrants, value	`StockIssuedDuringPeriodValueWarrants`	$609.00K	USD	1 Quarter
Acquisition of warrants, Amount	`StockIssuedDuringPeriodValueAcquisitions`	$27.95M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.13M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$286.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$797.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.06M	USD	1 Quarter
Restricted Stock Units Vested	`RestrictedStockUnitsVested`	$-67.00K	USD	1 Quarter
Restricted Stock Units Vested	`RestrictedStockUnitsVested`	$-126.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.51M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.37M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.84M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.20M	USD	1 Quarter
Preferred stock conversion, Value	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$111.28M	USD	1 Quarter
Issuance of common stock in connection with Business Combination and PIPE offering, net of issuance costs, Amount	`IssuanceOfCommonStockInConnectionWithBusinessCombinationAndPipeOfferingNetOfIssuanceCostsAmount`	$185.74M	USD	1 Quarter
Issuance of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$125.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.38M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-12.74M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-30.44M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.18M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-23.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-20.36M	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$176.28M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-109.20M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-98.90M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$202.26M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$192.27M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$157.25M	USD	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	157.37M	shares	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	152.86M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.